A novel accessory molecule trim59 involved in cytotoxicity of BCG-Activated macrophages

Molecules and Cells

Volumn 34, Issue 3, 2012, Pages 263-270

  Zhao, Xiang Feng ^a   Liu, Qihui ^a   Du, Baiqiu ^b   Li, Peng ^a   Cui, Qu ^a   Han, Xiao ^a   Du, Bairong ^a   Yan, Dongmei ^a   Zhu, Xun ^a  

^a Basic Medical College   (China)

^b Children's hospital of Changchun   (China)

Author keywords

Accessory molecule; BCG activated macrophages; Cytotoxicity; Trim59

Indexed keywords

BACTERIAL PROTEIN; BCG VACCINE; POLYCLONAL ANTIBODY; RECOMBINANT PROTEIN; TRIM59 RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BCG ACTIVATED MACROPHAGE; BRAIN; CELL INTERACTION; CYTOTOXICITY; ESCHERICHIA COLI; FEMALE; HEART; IMMUNOHISTOCHEMISTRY; INTESTINE; KIDNEY; LIVER; LUNG; MACROPHAGE; MOUSE; MUSCLE; NONHUMAN; OVARY; PHAGOCYTOSIS; PINOCYTOSIS; PROTEIN EXPRESSION; SPLEEN; STOMACH; THYMUS; TUMOR CELL; UTERUS;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CARRIER PROTEINS; CELLS, CULTURED; CLONING, MOLECULAR; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GENE EXPRESSION PROFILING; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM BOVIS; PHAGOCYTOSIS;

EID: 84870331623     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.1007/s10059-012-0089-z     Document Type: Article

References (32)

1. Adams, D.O., and Koren, H.S. (1979). BCG-activated macrophages: Comparison as effectors in direct tumor-cell cytotoxicity and antibody dependent cell-mediated cytotoxicity. Adv. Exp. Med. Biol. 121B, 195-201.
2. Atkinson, S., Valadas, E., Smith, S.M., Lukey, P.T., and Dockrell, H.M. (2000). Monocyte-derived macrophage cytokine responses induced by M. bovis BCG. Tuber Lung Dis. 80, 197-207.
3. Bai, G., Schaak, D.D., and McDonough, K.A. (2009). cAMP levels within Mycobacterium tuberculosis and Mycobacterium bovis BCG increase upon infection of macrophages. FEMS Immunol. Med. Microbiol. 55, 68-73.
4. Borden, K.L. (1998). RING fingers and B-boxes: Zinc-binding protein-protein interaction domains. Biochem. Cell Biol. 76, 351-358.
5. Borden, K.L., and Freemont, P.S. (1996). The RING finger domain: A recent example of a sequence-structure family. Curr. Opin. Struct. Biol. 6, 395-401.
6. Calorini, L., Bianchini, F., Mannini, A., Mugnai, G., Balzi, M., Becciolini, A., and Ruggieri, S. (2002). IFNgamma and TNFalpha account for a pro-clonogenic activity secreted by activated murine peritoneal macrophages. Clin. Exp. Metastasis 19, 259-264.
7. Chang, R., Xu, X., and Li, M.D. (2002). Molecular cloning, mapping and characterization of a novel mouse RING finger gene, Mrf1. Gene 291, 241-249.
8. Cleveland, R.P., Meltzer, M.S., and Zbar, B. (1974). Tumor cytotoxicity in vitro by macrophages from mice infected with mycobacterium bovis strain BCG. J. Nat. Cancer Inst. 52, 1887-1895.
9. DiStefano, J.F., Beck, G., and Zucker, S. (1983). Mechanism of BCG-activated macrophage-induced tumor cell cytotoxicity: Evidence for both oxygen-dependent and independent mechanisms. Int. Arch. Allergy Appl. Immunol. 70, 252-260.
10. Ge, J., Wang, Y., Feng, Y., Liu, H., Cui, X., Chen, F., Tai, G., and Liu, Z. (2009). Direct effects of activin A on the activation of mouse macrophage RAW264.7 cells. Cell. Mol. Immunol. 6, 129-133.
11. Giri, P.K., and Schorey, J.S. (2008). Exosomes derived from M. Bovis BCG infected macrophages activate antigen-specific CD4+ and CD8+ T cells in vitro and in vivo. PloS One 3, e2461.
12. Klostergaard, J., Leroux, M.E., Ezell, S.M., and Kull, F.C. Jr. (1987). Tumoricidal effector mechanisms of murine Bacillus Calmette-Guerin-activated macrophages: Mediation of cytolysis, mitochondrial respiration inhibition, and release of intracellular iron by distinct mechanisms. Cancer Res. 47, 2014-2019.
13. Laity, J.H., Lee, B.M., and Wright, P.E. (2001). Zinc finger proteins: New insights into structural and functional diversity. Curr. Opin. Struct. Biol. 11, 39-46.
14. Luo, Y., Yamada, H., Evanoff, D.P., and Chen, X. (2006). Role of Th1-stimulating cytokines in bacillus Calmette-Guerin (BCG)-induced macrophage cytotoxicity against mouse bladder cancer MBT-2 cells. Clini. Exp. Immunol. 146, 181-188.
15. MacKay, R.J., and Russell, S.W. (1986). Protein changes associated with stages of activation of mouse macrophages for tumor cell killing. J. Immunol. 137, 1392-1398.
16. MacKay, R.J., and Russell, S.W. (1987). Protein phenotypes of mouse macrophages activated in vivo for tumor cell killing. J. Leukoc. Biol. 42, 213-221.
17. Meltzer, M.S., and Stevenson, M.M. (1977). Macrophage function in tumor-bearing mice: Tumoricidal and chemotactic responses of macrophages activated by infection with Mycobacterium bovis, strain BCG. J. Immunol. 118, 2176-2181.
18. Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63.
19. Nascimento, F.R., Ribeiro-Dias, F., and Russo, M. (1998). Cytotoxic activity of BCG-activated macrophages against L929 tumor cells is nitric oxide-dependent. Braz. J. Med. Biol. Res. 31, 1593-1596.
20. Ouyang, P., and Sugrue, S.P. (1996). Characterization of pinin, a novel protein associated with the desmosome-intermediate filament complex. J. Cell Biol. 135, 1027-1042.
21. Ozato, K., Shin, D.M., Chang, T.H., and Morse, H.C., 3rd (2008). TRIM family proteins and their emerging roles in innate immunity. Nat. Rev. 8, 849-860.
22. Reymond, A., Meroni, G., Fantozzi, A., Merla, G., Cairo, S., Luzi, L., Riganelli, D., Zanaria, E., Messali, S., Cainarca, S., et al. (2001). The tripartite motif family identifies cell compartments. EMBO J. 20, 2140-2151.
23. Rual, J. F., Venkatesan, K., Hao, T., Hirozane-Kishikawa, T., Dricot, A., Li, N., Berriz, G.F., Gibbons, F.D., Dreze, M., Ayivi-Guedehoussou, N., et al. (2005). Towards a proteome-scale map of the human protein-protein interaction network. Nature 437, 1173-1178.
24. Torok, M., and Etkin, L.D. (2001). Two B or not two B? Overview of the rapidly expanding B-box family of proteins. Differentiation 67, 63-71.
25. Tsung, K., Dolan, J.P., Tsung, Y.L., and Norton, J.A. (2002). Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection. Cancer Res. 62, 5069-5075.
26. Valiyeva, F., Jiang, F., Elmaadawi, A., Moussa, M., Yee, S.P., Raptis, L., Izawa, J.I., Yang, B.B., Greenberg, N.M., Wang, F., et al. (2011). Characterization of the oncogenic activity of the novel TRIM59 gene in mouse cancer models. Mol. Cancer Ther. 10, 1229-1240.
27. Vitale, N., Pacheco-Rodriguez, G., Ferrans, V.J., Riemenschneider, W., Moss, J., and Vaughan, M. (2000). Specific functional interaction of human cytohesin-1 and ADP-ribosylation factor domain protein (ARD1). J. Biol. Chem. 275, 21331-21339.
28. Wang, J., Wakeham, J., Harkness, R., and Xing, Z. (1999). Macrophages are a significant source of type 1 cytokines during mycobacterial infection. J. Clin. Invest. 103, 1023-1029.
29. Zhang, L., Lun, Y., Yan, D., Yu, L., Ma, W., Du, B., and Zhu, X. (2007a). Proteomic analysis of macrophages: A new way to identify novel cell-surface antigens. J. Immunol. Methods 321, 80-85.
30. Zhang, L., Zhu, H., Lun, Y., Yan, D., Yu, L., Du, B., and Zhu, X. (2007b). Proteomic analysis of macrophages: A potential way to identify novel proteins associated with activation of macrophages for tumor cell killing. Cell. Mol. Immunol. 4, 359-367.
31. Zhao, X., Zhang, L., Yan, D., Feng, X., Chu, D., Li, B., Du, B., and Zhu, X. (2011). Phylogenetic analysis and prokaryotic expression of NMAAP1 derived from BCG-activated murine macrophages. Comp. Immunol. Microbiol. Infect. Dis. 34, 123-128.
32. Zwilling, B.S., and Campolito, L.B. (1977). Destruction of tumor cells by BCG-activated alqolar macrophages. J. Immunol. 119, 838-841.